BioSpace News Archive

Business

After Failing to Gain FTC Approval, Sandoz and Aurobindo Call Off $1 Billion Deal

Under terms of the deal, Aurobindo would pay $900 million upfront with an additional $100 million in milestone payments. However, in a filing with the Securities and Exchange Commission, the company announced it had terminated that agreement.

April 2, 2020
·
2 min read
·
Alex Keown
Drug Development

OSE Lung Cancer Trial Hits the Mark, But COVID-19 Could Delay Ongoing Clinical Plans

A late-stage lung cancer drug under development by OSE Immunotherapeutics met its 12-month primary endpoint for survival rates following a Step-1 analysis.

April 2, 2020
·
2 min read
·
Alex Keown
Pharm Country

IBM Offers “Watson Assistant for Citizens” to Provide Responses to COVID-19 Questions

Engagements with government agencies, healthcare organizations and academic institutions around the world including in Arkansas, California, Georgia, New York, Texas, Czech Republic, Greece, Poland, Spain and UK

April 2, 2020
·
6 min read
Hand Sanitizers Market to Grow with Rising Hygiene Awareness

Globally, people are now more aware about there about various diseases and are more health conscious.

April 2, 2020
·
3 min read
Botulinum Toxin Market is projected to reach US$ 8,718.7 million by 2026 - TMR

The pressing need for quality and the identification of new applications sustains the competition in the global botulinum toxin market, says a recent report by Transparency Market Research.

April 2, 2020
·
4 min read
Oncology Nutrition Market: Progress in Nutritional Screening and Assessment Techniques to Drive Market

Transparency Market Research has published a new report titled, “Global Oncology nutrition Market”.

April 2, 2020
·
4 min read
Business

Hansa Biopharma Publishes Annual Report 2019

Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced the release of the Annual Report 2019

April 2, 2020
·
3 min read
Policy

Small NJ Biotech Firm, BioAegis Therapeutics, Accelerating Multiple Clinical Trial Submissions for Severe COVID-19 Pneumonia Patients

BioAegis Therapeutics Inc. is a clinical stage, private company focused on developing therapies for infectious, inflammatory, and degenerative diseases.

April 2, 2020
·
4 min read
Business

Oncopeptides Strengthens its Corporate Communications Function by Appointing Rolf Gulliksen as Global Head of Corporate Communications

Oncopeptides AB announced that Rolf Gulliksen has been appointed global head of corporate communications.

April 2, 2020
·
2 min read
Jolly Good and National Center for Cognitive Behavior Therapy and Research Enter Clinical Trial Collaboration for VR Therapeutics

Partnership Aims to Develop World’s First Cognitive Behavioral Therapy VR for Patients with Depression

April 2, 2020
·
2 min read